טוען...
Presence of a SARS-COV-2 protein enhances Amyloid Formation of Serum Amyloid A
A marker for the severeness and disease progress of COVID-19 is overexpression of serum amyloid A (SAA) to levels that in other diseases are associated with a risk for SAA amyloidosis. In order to understand whether SAA amyloidosis could also be a long-term risk of SARS-COV-2 infections we have used...
שמור ב:
| הוצא לאור ב: | bioRxiv |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cold Spring Harbor Laboratory
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142650/ https://ncbi.nlm.nih.gov/pubmed/34031653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.05.18.444723 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|